Skip to main content
BRTX logo

BRTX · BioRestorative Therapies, Inc.

$0.25 -0.02 (-7.31%) At close · Jul 29
Market Cap
$6.79M
Shares
25.48M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$2,000,000
as of 2025-06-16 · from 10-Q (reviewed)· expired 2026-06-16
Remaining Authorization
$2,000,000
as of 2026-03-31 · from 10-Q (reviewed)
Program Utilization
0.0% $0 used of $2,000,000

Repurchase Programs

Program Announced Authorized Remaining Runs Through
2025-06-16 $2,000,000 $2,000,000 2026-06-16 expired

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2024-11-01 $3,614,000

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-03-31 YTD $0
2025-12-31 $0
2014-03-31 $32,000
2013-12-31 $32,000
2013-09-30 $32,000
2013-06-30 $32,000
2013-03-31 $32,000
2012-12-31 $0
2012-09-30 $32,000
2012-06-30 $32,000
2012-03-31 $32,000
2011-12-31 $4,000
2011-09-30 $28,000
2011-06-30 $28,000
2010-12-31 $28,000
Key facts CIK 1505497 CUSIP 090655606 13F (30d) 3 filings 3 filers Visit website Investor relations